Iradimed Non Current Liabilities Total vs Common Stock Shares Outstanding Analysis

IRMD Stock  USD 52.63  1.80  3.31%   
Iradimed financial indicator trend analysis is infinitely more than just investigating Iradimed recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Iradimed is a good investment. Please check the relationship between Iradimed Non Current Liabilities Total and its Common Stock Shares Outstanding accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Non Current Liabilities Total vs Common Stock Shares Outstanding

Non Current Liabilities Total vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Iradimed Non Current Liabilities Total account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have strong relationship.
The correlation between Iradimed's Non Current Liabilities Total and Common Stock Shares Outstanding is 0.76. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Iradimed Co, assuming nothing else is changed. The correlation between historical values of Iradimed's Non Current Liabilities Total and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Iradimed Co are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Non Current Liabilities Total i.e., Iradimed's Non Current Liabilities Total and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

0.76
Relationship DirectionPositive 
Relationship StrengthSignificant

Non Current Liabilities Total

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most indicators from Iradimed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Iradimed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
At present, Iradimed's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 51.09, whereas Selling General Administrative is forecasted to decline to about 9.3 M.
 2021 2022 2023 2024 (projected)
Gross Profit32.0M41.3M50.2M27.1M
Total Revenue41.8M53.3M65.6M35.1M

Iradimed fundamental ratios Correlations

0.590.550.681.00.780.680.94-0.970.990.770.980.760.510.420.980.780.940.87-0.130.910.630.650.950.790.7
0.590.070.190.620.710.240.46-0.530.560.420.540.290.160.390.660.280.770.640.680.520.240.310.710.30.18
0.550.070.970.510.260.950.47-0.570.490.580.470.930.13-0.140.440.810.560.56-0.430.470.950.220.520.920.96
0.680.190.970.650.420.950.64-0.70.640.70.60.970.29-0.050.590.90.670.69-0.370.580.980.30.630.980.99
1.00.620.510.650.780.650.93-0.980.990.750.990.730.530.450.990.760.940.87-0.10.90.60.670.960.760.67
0.780.710.260.420.780.510.73-0.750.810.440.750.570.240.620.80.490.740.760.160.890.430.490.670.580.43
0.680.240.950.950.650.510.57-0.70.630.570.610.980.090.10.60.80.680.69-0.340.670.950.40.630.970.96
0.940.460.470.640.930.730.57-0.920.960.740.930.680.680.370.910.790.80.79-0.220.820.580.590.830.730.65
-0.97-0.53-0.57-0.7-0.98-0.75-0.7-0.92-0.97-0.68-0.99-0.77-0.53-0.44-0.98-0.79-0.88-0.880.23-0.89-0.63-0.72-0.92-0.8-0.72
0.990.560.490.640.990.810.630.96-0.970.720.990.720.540.460.980.750.880.86-0.170.920.580.680.90.760.65
0.770.420.580.70.750.440.570.74-0.680.720.680.670.640.00.680.860.780.71-0.070.570.670.120.760.70.71
0.980.540.470.60.990.750.610.93-0.990.990.680.690.540.480.990.720.870.84-0.210.910.530.740.920.730.63
0.760.290.930.970.730.570.980.68-0.770.720.670.690.270.130.680.890.740.75-0.340.720.960.390.691.00.98
0.510.160.130.290.530.240.090.68-0.530.540.640.540.270.160.510.650.390.41-0.220.340.210.10.470.320.34
0.420.39-0.14-0.050.450.620.10.37-0.440.460.00.480.130.160.490.040.350.350.040.59-0.060.560.390.120.02
0.980.660.440.590.990.80.60.91-0.980.980.680.990.680.510.490.710.920.87-0.070.890.540.710.950.710.61
0.780.280.810.90.760.490.80.79-0.790.750.860.720.890.650.040.710.730.76-0.340.650.850.230.730.910.92
0.940.770.560.670.940.740.680.8-0.880.880.780.870.740.390.350.920.730.860.150.80.670.540.980.750.68
0.870.640.560.690.870.760.690.79-0.880.860.710.840.750.410.350.870.760.860.010.760.680.520.850.780.69
-0.130.68-0.43-0.37-0.10.16-0.34-0.220.23-0.17-0.07-0.21-0.34-0.220.04-0.07-0.340.150.01-0.19-0.25-0.240.04-0.36-0.41
0.910.520.470.580.90.890.670.82-0.890.920.570.910.720.340.590.890.650.80.76-0.190.530.630.80.740.62
0.630.240.950.980.60.430.950.58-0.630.580.670.530.960.21-0.060.540.850.670.68-0.250.530.250.590.950.97
0.650.310.220.30.670.490.40.59-0.720.680.120.740.390.10.560.710.230.540.52-0.240.630.250.610.410.31
0.950.710.520.630.960.670.630.83-0.920.90.760.920.690.470.390.950.730.980.850.040.80.590.610.720.65
0.790.30.920.980.760.580.970.73-0.80.760.70.731.00.320.120.710.910.750.78-0.360.740.950.410.720.98
0.70.180.960.990.670.430.960.65-0.720.650.710.630.980.340.020.610.920.680.69-0.410.620.970.310.650.98
Click cells to compare fundamentals

Iradimed Account Relationship Matchups

Iradimed fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets66.7M71.1M82.9M85.5M92.2M54.5M
Other Current Liab3.0M2.0M3.1M3.0M10.7M11.2M
Total Current Liabilities5.9M4.9M6.8M8.6M16.3M17.1M
Total Stockholder Equity55.5M61.4M72.2M73.7M71.4M46.1M
Other Liab2.6M2.3M1.7M1.4M1.6M1.4M
Property Plant And Equipment Net5.0M4.8M4.6M2.4M11.3M11.9M
Current Deferred Revenue1.7M1.9M2.6M3.4M2.6M1.7M
Net Debt(40.5M)(47.4M)(59.5M)(55.8M)(47.7M)(45.3M)
Retained Earnings36.3M37.7M47.0M47.3M43.3M27.5M
Accounts Payable993.7K657.1K782.9K1.8M1.9M1.0M
Cash43.5M50.1M62.0M58.0M49.8M33.0M
Non Current Assets Total7.8M7.3M6.6M7.3M16.2M17.0M
Non Currrent Assets Other232.0K262.0K201.3K2.2M181.4K336.3K
Other Assets1.9M6.4M966.4K1.3M1.00.95
Cash And Short Term Investments46.3M52.0M62.5M58.0M49.8M37.0M
Net Receivables7.3M4.6M5.1M13.3M12.2M12.8M
Common Stock Total Equity1.2K1.2K1.3K1.3K1.4K1.2K
Common Stock Shares Outstanding12.3M12.4M12.6M12.6M12.7M13.0M
Short Term Investments8.1M6.3M2.8M1.9M501.9K0.0
Liabilities And Stockholders Equity66.7M71.1M82.9M85.5M92.2M54.5M
Non Current Liabilities Total5.3M4.8M3.9M3.3M4.4M2.5M
Inventory3.6M3.9M4.3M5.4M12.8M13.5M
Other Current Assets407.8K3.2M4.3M885.1K1.2M1.1M
Other Stockholder Equity19.2M23.7M25.2M26.4M28.2M18.5M
Total Liab11.2M9.7M10.7M11.8M20.7M21.8M
Property Plant And Equipment Gross5.0M4.8M4.6M8.0M15.4M16.2M
Total Current Assets59.0M63.7M76.2M78.2M76.0M49.0M
Accumulated Other Comprehensive Income(42.2K)30.4K37.1K17.0K19.6K20.5K
Short Term Debt240.8K255.7K276.6K293.5K855.9K528.0K
Intangible Assets860.1K960.9K1.1M2.1M2.5M2.6M
Common Stock1.2K1.2K1.3K1.3K1.3K1.2K
Property Plant Equipment2.1M2.1M4.6M2.4M2.8M1.9M
Net Tangible Assets54.7M60.4M71.1M71.6M82.3M50.6M
Retained Earnings Total Equity36.3M37.7M47.0M47.3M54.4M30.9M
Capital Surpluse19.2M23.7M25.2M26.4M30.4M20.7M
Net Invested Capital55.5M61.4M72.2M73.7M71.4M64.3M
Net Working Capital53.1M58.8M69.4M69.6M59.7M60.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Iradimed is a strong investment it is important to analyze Iradimed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iradimed's future performance. For an informed investment choice regarding Iradimed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0)
Dividend Share
0.45
Earnings Share
1.46
Revenue Per Share
5.635
Quarterly Revenue Growth
0.11
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.